Hypoxia, lactate accumulation, and acidosis: siblings or accomplices driving tumor progression and resistance to therapy?

This chapter briefly summarizes the most important processes by which hypoxia, lactate accumulation, and acidosis may influence malignant progression and therapeutic resistance of solid malignant tumors. While these phenomena are often elements of an integrated reaction, they may occur independently of each other under certain circumstances. The latter information may be of interest with regard to possible "targeted" therapeutic interventions.

[1]  T. Morita,et al.  Clastogenicity of low pH to various cultured mammalian cells. , 1991, Mutation research.

[2]  I. Tannock,et al.  Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Gudkov,et al.  Hypoxia suppresses conversion from proliferative arrest to cellular senescence , 2012, Proceedings of the National Academy of Sciences.

[4]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[5]  P. De Baetselier,et al.  Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. , 2010, Cancer research.

[6]  R. McLendon,et al.  Acidic stress promotes a glioma stem cell phenotype , 2011, Cell Death and Differentiation.

[7]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[8]  A. Lardner.  The effects of extracellular pH on immune function , 2001, Journal of leukocyte biology.

[9]  Kou-Juey Wu,et al.  Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.

[10]  L. Huang,et al.  The phosphorylation status of PAS‐B distinguishes HIF‐1α from HIF‐2α in NBS1 repression , 2006 .

[11]  P. Vaupel,et al.  Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. , 1981, Cancer research.

[12]  R. Gillies,et al.  Microenvironmental and cellular consequences of altered blood flow in tumours. , 2003, The British journal of radiology.

[13]  J. Haveman.  The influence of pH on the survival after X-irradiation of cultured malignant cells. Effects of carbonylcyanide-3-chlorophenylhydrazone. , 1980, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[14]  C. Lewis,et al.  Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. , 2005, The American journal of pathology.

[15]  B. Wouters,et al.  Hypoxia signalling through mTOR and the unfolded protein response in cancer , 2008, Nature Reviews Cancer.

[16]  G. Semenza.  Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. , 2011, Biochimica et biophysica acta.

[17]  Peter Vaupel,et al.  Tumor microenvironmental physiology and its implications for radiation oncology. , 2004, Seminars in radiation oncology.

[18]  Franziska Hirschhaeuser,et al.  Lactate: a metabolic key player in cancer. , 2011, Cancer research.

[19]  O. Thews,et al.  Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs. , 2006, Neoplasia.

[20]  R. Wenger,et al.  Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 alpha-deficient mouse embryonic fibroblasts. , 2008, Carcinogenesis.

[21]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[22]  P. Glazer,et al.  The tumor microenvironment and DNA repair. , 2010, Seminars in radiation oncology.

[23]  P. Vaupel,et al.  The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies , 2009 .

[24]  P. Vaupel.  Physiological Mechanisms of Treatment Resistance , 2009 .

[25]  F. Bianchini,et al.  Extracellular acidity as favouring factor of tumor progression and metastatic dissemination. , 2012, Experimental oncology.

[26]  G. Semenza.  Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. , 2012, Trends in pharmacological sciences.

[27]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[28]  G. Semenza,et al.  Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.

[29]  I. Melero,et al.  Molecular Pathways: Hypoxia Response in Immune Cells Fighting or Promoting Cancer , 2011, Clinical Cancer Research.

[30]  C. Dang,et al.  Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.

[31]  M. Baumann,et al.  Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts , 2009, International journal of radiation biology.

[32]  R K Jain,et al.  Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. , 2001, Cancer research.

[33]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[34]  M. Sitkovsky,et al.  Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors , 2005, Nature Reviews Immunology.

[35]  Lin Zhang,et al.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells , 2011, Nature.

[36]  L. Gunaratnam,et al.  HIF activation by pH-dependent nucleolar sequestration of VHL , 2004, Nature Cell Biology.

[37]  Bonnie F. Sloane,et al.  Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. , 2012, Cancer research.

[38]  G. Semenza,et al.  Metabolic regulation of hematopoietic stem cells in the hypoxic niche. , 2011, Cell stem cell.